WuXi AppTec News More News
WuXi AppTec Historical Prices
| Date | Open | Close | Daily High | Daily Low |
|---|
Price change over selected period:
0%
0
WuXi AppTec Analyst Opinions
- All
- Buy
- Hold
- Sell
WuXi AppTec Estimates* in HKD
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Revenue | 50,872 | 65,173 | 78,779 | - |
| Dividend | 0.72 | 0.93 | - | - |
| Dividend Yield (in %) | 0.93 % | 1.19 % | - | - |
| EPS | 3.71 | 4.74 | - | - |
| P/E Ratio | 20.28 | 15.88 | - | - |
| EBIT | 12,385 | 15,966 | 17,922 | 27,362 |
| EBITDA | 14,754 | 18,693 | - | - |
| Net Profit | 11,052 | 14,104 | 15,319 | - |
| Net Profit Adjusted | 10,789 | 13,883 | - | - |
| Pre-Tax Profit | 12,886 | 16,579 | 18,131 | - |
| Net Profit (Adjusted) | 12,915 | 16,362 | - | - |
| EPS (Non-GAAP) ex. SOE | - | - | - | - |
| EPS (GAAP) | 3.62 | 4.58 | - | - |
| Gross Income | 19,223 | 25,025 | 28,597 | - |
| Cash Flow from Investing | -6,518 | -6,128 | - | - |
| Cash Flow from Operations | 12,215 | 13,611 | - | - |
| Cash Flow from Financing | -2,197 | -2,978 | - | - |
| Cash Flow per Share | 3.98 | 4.33 | - | - |
| Free Cash Flow | 3,338 | 6,912 | 8,345 | 14,950 |
| Free Cash Flow per Share | 1.73 | 2.30 | - | - |
| Book Value per Share | 20.86 | 24.62 | - | - |
| Net Debt | -6,268 | -9,593 | - | - |
| Research & Development Exp. | 1,960 | 2,570 | 2,758 | - |
| Capital Expenditure | 7,367 | 7,044 | 11,551 | 10,069 |
| Selling, General & Admin. Exp. | 6,499 | 8,145 | - | - |
| Shareholder’s Equity | 62,524 | 74,388 | - | - |
| Total Assets | 86,877 | 103,501 | - | - |
|
Previous Quarter ending 12/31/22 |
Current Quarter | Next Quarter |
Current Year ending 12/31/23 |
Next Year ending 12/31/24 |
|
|---|---|---|---|---|---|
| Earnings Estimates | |||||
| No. of Analysts | 3 | 1 | 1 | 30 | 30 |
| Average Estimate | 0.641 HKD | 0.661 HKD | 0.708 HKD | 3.711 HKD | 4.740 HKD |
| Year Ago | - | 0.635 HKD | - | - | 3.711 HKD |
| Publish Date | 3/20/2023 | 5/2/2023 | 8/22/2023 | - | - |
| Revenue Estimates | |||||
| No. of Analysts | 3 | - | - | 28 | 28 |
| Average Estimate | 12,247 HKD | - | - | 50,872 HKD | 65,173 HKD |
| Year Ago | - | - | - | - | 50,872 HKD |
| Publish Date | 3/20/2023 | - | - | - | - |
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet
WuXi AppTec Dividend Calendar
| Date | Name | Dividend | *yield | Currency |
|---|---|---|---|---|
| 2021 | WuXi AppTec Co., Ltd. Registered Shs -H- Unitary Reg S-144A | 0.62 | 0.56 | HKD |
| 2020 | WuXi AppTec Co., Ltd. Registered Shs -H- Unitary Reg S-144A | 0.36 | 0.34 | HKD |
| 2019 | WuXi AppTec Co., Ltd. Registered Shs -H- Unitary Reg S-144A | 0.22 | 0.43 | HKD |
| 2018 | WuXi AppTec Co., Ltd. Registered Shs -H- Unitary Reg S-144A | 0.28 | 1.11 | HKD |
| 2017 | WuXi AppTec Co., Ltd. Registered Shs -H- Unitary Reg S-144A | - | - | HKD |
| 2016 | WuXi AppTec Co., Ltd. Registered Shs -H- Unitary Reg S-144A | - | - | HKD |
| 2015 | WuXi AppTec Co., Ltd. Registered Shs -H- Unitary Reg S-144A | - | - | HKD |
*Yield of the Respective Date
WuXi AppTec Co., Ltd. Registered Shs -H- Unitary Reg S-144A Calendar
| Event | Estimate | Info | Date |
|---|---|---|---|
| Earnings Report | 0.641 HKD | Q4 2022 Earnings Release | 03/20/2023 |
| Earnings Report | 0.661 HKD | Q1 2023 Earnings Release | 05/02/2023 |
| Earnings Report | 0.708 HKD | Q2 2023 Earnings Release | 08/22/2023 |
| Earnings Report | - | Q3 2023 Earnings Release | 11/02/2023 |
| Earnings Report | - | Q4 2023 Earnings Release | 03/20/2024 |
WuXi AppTec Profile
WuXi AppTec Co., Ltd. provides an integrated pharmaceutical platform for the research, development, and production of new drugs. It operates through the following business segments: Contract research organization (CRO) services, Contract manufacturing organization (CMO)/Contract development and manufacturing organization (CDMO) business, and Others. The CRO services segment includes laboratory services in China, laboratory services in the United States, and clinical research services. The company was founded by Ge Li, Ning Zhao, Xiao Zhong Liu, Zhao Hui Zhang, and Tao Lin on December 1, 2000 and is headquartered in Shanghai, China.
Moody’s Daily Credit Risk Score
WuXi AppTec Shareholder
| Owner | in % |
|---|---|
| Freefloat | 90.09 |
| Qatar Holding LLC | 9.66 |
| Wellington Management Co. LLP | 4.61 |
| American Funds New Economy Fund | 2.77 |
| Vanguard Health Care Fund | 2.49 |
| FIL Investment Management (Hong Kong) Ltd. | 2.32 |
| Qatar Investment Authority (Investment Management) | 2.11 |
| Vanguard Total International Stock Index Fund | 1.15 |
| American Funds New World Fund | 1.03 |
| WCM Focused Emerging Markets Fund | 0.88 |
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.